These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9736290)

  • 1. Preventive strategies in endothelin-induced renal failure.
    Hermann M; Schulz E; Ruschitzka F; Müller GA
    Kidney Int Suppl; 1998 Sep; 67():S202-4. PubMed ID: 9736290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1-induced vasopressor responses in essential hypertension.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
    Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1995 Apr; 25(4 Pt 1):620-5. PubMed ID: 7721406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cilnidipine on renal function in SHR and endothelin-induced renal dysfunction].
    Dozen M; Watanabe K; Hosono M; Hayashi Y
    Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):79-89. PubMed ID: 8721010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects.
    Fricker AF; Nussberger J; Meilenbrock S; Brunner HR; Burnier M
    Kidney Int; 1998 Dec; 54(6):2089-97. PubMed ID: 9853274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: effect of enalapril and nifedipine.
    Monteiro de Freitas AS; Coimbra TM; Costa RS; Baroni EA
    Nephron; 1998; 78(3):302-9. PubMed ID: 9546691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
    Kvam FI; Ofstad J; Iversen BM
    Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of endothelin and Ca++ entry blockers on renal circulation in anesthetized rabbits.
    Seino M; Abe K; Nushiro N; Omata K; Tsunoda K; Yoshinaga K; Kasai Y; Saito T; Sasao S
    Clin Exp Hypertens A; 1990; 12(2):205-13. PubMed ID: 2189604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
    Dukacz SA; Kline RL
    J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
    Cirino M; Martin E; Yano M; Rodger IW
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin.
    Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of big endothelin-1-induced diuresis and natriuresis : role of ET(B) receptors.
    Hoffman A; Abassi ZA; Brodsky S; Ramadan R; Winaver J
    Hypertension; 2000 Mar; 35(3):732-9. PubMed ID: 10720587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
    Miura K; Yukimura T; Yamashita Y; Shimmen T; Okumura M; Yamanaka S; Imanishi M; Yamamoto K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):11-7. PubMed ID: 1988651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin and cyclosporine nephrotoxicity.
    Kon V; Awazu M
    Ren Fail; 1992; 14(3):345-50. PubMed ID: 1324512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of a calcium antagonist against renal vasoconstriction induced by endothelin in the normotensive rat].
    Madeddu P; Pala F; Troffa C; Pinna Parpaglia P; Pazzola A; Soro A; Manunta P; Tonolo G; Melis MG; Demontis MP
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):671-8. PubMed ID: 2083061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal responses to angiotensin-converting enzyme inhibition in the neonatal pig.
    Nilsson AB; Friberg P
    Pediatr Nephrol; 2000 Oct; 14(12):1071-6. PubMed ID: 11045389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.